Skip to Content

BlackRock Health Sciences Opps K SHSKX

Medalist Rating as of | See BlackRock Investment Hub
  • NAV / 1-Day Return 71.77  /  +0.15 %
  • Total Assets 8.1 Bil
  • Adj. Expense Ratio
    0.750%
  • Expense Ratio 0.750%
  • Distribution Fee Level Low
  • Share Class Type Retirement, Large
  • Category Health
  • Investment Style Large Blend
  • Min. Initial Investment 5.0 Mil
  • Status Open
  • TTM Yield 0.51%
  • Turnover 29%

USD | NAV as of Apr 19, 2024 | 1-Day Return as of Apr 19, 2024, 10:18 PM GMT+0

Morningstar’s Analysis SHSKX

Will SHSKX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

BlackRock Health Sciences Opps K’s Process Pillar rating is Average, but a strong management team still helps this strategy retain its Morningstar Medalist Rating of Bronze.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The portfolio maintains a sizable cost advantage over competitors, priced within the second-cheapest fee quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings SHSKX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 49.2
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Eli Lilly and Co

10.00 848.0 Mil
Healthcare

UnitedHealth Group Inc

8.32 705.3 Mil
Healthcare

AbbVie Inc

5.32 451.4 Mil
Healthcare

Boston Scientific Corp

4.89 414.9 Mil
Healthcare

Merck & Co Inc

4.80 407.4 Mil
Healthcare

Abbott Laboratories

3.66 310.0 Mil
Healthcare

Amgen Inc

3.39 287.8 Mil
Healthcare

Danaher Corp

3.24 275.1 Mil
Healthcare

Stryker Corp

2.79 236.2 Mil
Healthcare

Intuitive Surgical Inc

2.76 234.2 Mil
Healthcare